Finance

Lists
069620:KRX
Daewoong Pharmaceutical
၁၀၆,၂၀၀.၀၀ ₩
-၁.၄၈%
(-၁,၆၀၀.၀၀) 1D
အောက် ၂၀, GMT+၉ ၀၉:၄၆:၂၆  ·   KRW
All symbols
SymbolPriceChange% Change
Generating top insights for 069620...
Open
၁၀၅,၇၀၀ ₩
High
၁၀၉,၅၀၀ ₩
Low
၁၀၅,၅၀၀ ₩
Mkt. cap
ဋေ ၁.၂၃ သိန်း
Avg. vol.
၁.၉၁ သောင်း
Volume
၅.၁၂ ထောင်
Dividend
၀.၅၆%
Quarterly dividend
၁၅၀ ₩
Ex-dividend date
၂၀၂၃ ဒီ ၂၇
P/E ratio
၆.၂၅
52-wk high
၁၉၉,၄၀၀ ₩
52-wk low
၁၀၁,၉၀၀ ₩
EPS
၁၆,၉၈၈ ₩
Shares outstanding
၁.၁၆ ကုဋေ
No. of employees
၂ ထောင်
Open
၁၀၅,၇၀၀ ₩
High
၁၀၉,၅၀၀ ₩
Low
၁၀၅,၅၀၀ ₩
Mkt. cap
ဋေ ၁.၂၃ သိန်း
Avg. vol.
၁.၉၁ သောင်း
Volume
၅.၁၂ ထောင်
Dividend
၀.၅၆%
Quarterly dividend
၁၅၀ ₩
Ex-dividend date
၂၀၂၃ ဒီ ၂၇
P/E ratio
၆.၂၅
52-wk high
၁၉၉,၄၀၀ ₩
52-wk low
၁၀၁,၉၀၀ ₩
EPS
၁၆,၉၈၈ ₩
Shares outstanding
၁.၁၆ ကုဋေ
No. of employees
၂ ထောင်
News stories
From web sources and news partners
ad-hoc-news.de
ad-hoc-news.de
·
ပြီးခဲ့သည့် ၅၆ မိနစ်
KB Securities cuts target for Daewoong Pharmaceutical stock to KRW 200,000
Profile
Daewoong Pharmaceutical Co., Ltd. is a pharmaceutical company headquartered in Seoul, South Korea. Daewoong Pharmaceutical primarily engages in the manufacture of pharmaceutical products, including prescription and over-the-counter healthcare products. Wikipedia
About Daewoong Pharmaceutical
CEOChang-jae Lee | Seongsoo Park
Employees၁.၈၉ ထောင်
Founded၁၉၄၅
Headquarters-
Sector-
Previous reportsAll values in KRW
Loading Previous Earnings...
Revenue
Net income
All values in KRW
၂၀၂၅ စက်
၂၀၂၅ ဒီ
၂၀၂၆ မတ်
၂၀၂၆ ဇွန်
Revenue
ဋေ ၄.၁၂ သ
ဋေ ၃.၉၇ သ
ဋေ ၃.၇၈ သ
ဋေ ၄.၄၈ သ
Cost of goods sold
ဋေ ၁.၉၈ သ
ဋေ ၁.၈၆ သ
ဋေ ၁.၉၇ သ
ဋေ ၁.၉၉ သ
Cost of revenue
ဋေ ၁.၉၈ သ
ဋေ ၁.၈၆ သ
ဋေ ၁.၉၇ သ
ဋေ ၁.၉၉ သ
Research and development expenses
၈၃၁.၀၄ ဋေ
ဋေ ၁.၄၀ သ
ဋေ ၁.၆၁ ထ
ဋေ ၁.၄၈ ထ
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
ဋေ ၁.၄၄ သ
ဋေ ၂.၃၁ ထ
ဋေ ၁.၃၇ သ
ဋေ ၁.၅၅ သ
Operating expense
ဋေ ၁.၅၇ သ
ဋေ ၁.၆၉ သ
ဋေ ၁.၅၉ သ
ဋေ ၁.၈၁ သ
Total operating expenses
ဋေ ၃.၅၅ သ
ဋေ ၃.၅၅ သ
ဋေ ၃.၅၆ သ
ဋေ ၃.၈၀ သ
Operating income
ဋေ ၅.၆၉ ထ
ဋေ ၄.၂၁ ထ
ဋေ ၂.၂၂ ထ
ဋေ ၆.၈၁ ထ
Other non operating income
-၁၁၅.၆၆ ဋေ
၂၇၆.၈၈ ဋေ
၁၅၂.၃၄ ဋေ
-ဋေ ၃.၆၅ ထ
EBT including unusual items
ဋေ ၅.၄၇ ထ
ဋေ ၆.၉၀ ထ
ဋေ ၃.၄၀ ထ
ဋေ ၂.၁၉ ထ
EBT excluding unusual items
ဋေ ၅.၄၇ ထ
ဋေ ၈.၈၀ ထ
ဋေ ၁.၁၈ ထ
ဋေ ၂.၁၉ ထ
Income tax expense
၇၄၂.၃၀ ဋေ
-ဋေ ၁.၆၇ ထ
၈၄၅.၅၉ ဋေ
၁၉၇.၅၃ ဋေ
Effective tax rate
၁၃.၅၆%
-၂၄.၂၆%
၂၄.၈၉%
၉.၀၂%
Other operating expenses
၁၁၆.၉၂ ဋေ
၁၁၇.၁၉ ဋေ
၁၈၈.၁၈ ဋေ
၁၆၁.၄၀ ဋေ
Net income
ဋေ ၄.၆၄ ထ
ဋေ ၈.၉၈ ထ
ဋေ ၂.၅၉ ထ
ဋေ ၃.၃၄ ထ
Net profit margin
၁၁.၂၆%
၂၂.၆၂%
၆.၈၆%
၇.၄၄%
Earnings per share
-
-
-
-
Interest and investment income
-
၁၁၁.၇၅ ဋေ
၁၇၄.၂၁ ဋေ
-
Interest expense
-
-၃၅၂.၇၅ ဋေ
-၈၀၀.၃၆ ဋေ
-
Net interest expenses
-
-၂၄၁.၀၀ ဋေ
-၆၂၆.၁၅ ဋေ
-
Depreciation and amortization charges
၁၇၇.၂၆ ဋေ
၁၄၂.၅၃ ဋေ
၁၁၅.၄၆ ဋေ
၇၉၃.၉၉ ဋေ
EBITDA
ဋေ ၆.၉၄ ထ
ဋေ ၅.၆၀ ထ
ဋေ ၃.၈၄ ထ
ဋေ ၉.၃၀ ထ
Gain or loss from assets sale
-၁.၂၈ ကုဋေ
-ဋေ ၅.၂၃ ထ
၃.၅၀ ကုဋေ
-၇.၅၄ သန်း
AI content may include mistakes. Learn more
Google အက်ပ်များ